Fig. 2
From: Serum metabolic profiling in rheumatic heart disease and degenerative aortic stenosis
Exploration of the important metabolites that were detected and perturbed in RHD patients compared to controls. (a) Profile of perturbed amino acids and derivatives. (b) Profile of glycerophospholipid metabolites in RHD patients compared to controls. (c) Profile of the detected metabolites that regulate certain inflammatory responses. (For all the plots, RHD samples, n = 33; control samples, n = 16; *p value < 0.05; **p value < 0.01). (RHD rheumatic heart disease, LysoPE lysophosphatidylethanolamine, LysoPC lysophosphatidylcholine).
